Compugen Ltd. To Present Predictive Methodology For Discovery Of Novel Immune Checkpoints At The Washington BioLeaders Forum
Published: Jan 22, 2014
Compugen Ltd. (NASDAQ: CGEN) today announced that Dr. John Hunter of Compugen USA, Inc. will present at the Washington BioLeaders Forum 2014 to be held next week in Washington, D.C. In his talk, which is scheduled for January 28 in the Phacilitate Immunotherapy Forum track, Dr. Hunter will demonstrate how Compugen has applied its predictive discovery platforms to identify novel immune checkpoints for targeted antibody immunotherapy in cancer.
Help employers find you! Check out all the jobs and post your resume.